Cargando…

Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020

Background: The Centers for Disease Control and Prevention’s Emerging Infections Program conducts active laboratory- and population-based surveillance for carbapenem-resistant Enterobacterales (CRE) and extended spectrum beta-lactamase-producing Enterobacterales (ESBL-E). To better understand the U....

Descripción completa

Detalles Bibliográficos
Autores principales:	Grome, Heather, Grass, Julian, Duffy, Nadezhda, Bulens, Sandra, Jacob, Jesse, Smith, Gillian, Wilson, Lucy, Vaeth, Elisabeth, Evenson, Bailey, Dumyati, Ghinwa, Tsay, Rebecca, Phipps, Erin C., Flores, Kristina, Wilson, Christopher, Czaja, Christopher, Johnston, Helen, Lynfield, Ruth, O’Malley, Sean, Maloney, Meghan, Stabach, Nicole, Nadle, Joelle, Guh, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594107/ http://dx.doi.org/10.1017/ash.2023.231

Ejemplares similares

1928. Trends In Incidence of Carbapenem-Resistant Enterobacterales (CRE) In Seven US sites, 2016─2020
por: Duffy, Nadezhda, et al.
Publicado: (2023)

86. Antibiotic-resistant gram-negative bacterial infections among persons with or without a prior positive test for SARS-CoV-2 in 10 U.S. sites, 2020
por: Bulens, Sandra N, et al.
Publicado: (2022)

2458. Carbapenem-resistant Acinetobacter baumannii complex infections and SARS-CoV-2 positivity in 9 U.S. sites, 2020-2022
por: Bulens, Sandra N, et al.
Publicado: (2023)

507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017
por: See, Isaac, et al.
Publicado: (2019)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

Wide Range of Carbapenem-resistant Enterobacteriaceae Incidence and Trends in Emerging Infections Program Surveillance, 2012–2015
por: Duffy, Nadezhda, et al.
Publicado: (2017)

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2015)

1933. Characteristics of Community-Associated Extended-Spectrum β-Lactamase Producing Enterobacterales Infections in Monroe County, NY, 2020-2021
por: Tellerman, Julia, et al.
Publicado: (2023)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

1162. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified Through the Emerging Infections Program (EIP), United States, 2016–2017
por: Grass, Julian, et al.
Publicado: (2018)

469. Contributions of Infections among Persons Who Inject Drugs to the Changing Incidence of Healthcare-Associated, Community-Onset Methicillin-Resistant Staphylococcus aureus Infections, 2009–2017
por: Jackson, Kelly A, et al.
Publicado: (2019)

Distinct Origins and Transmission Pathways of bla(KPC) Enterobacterales across Three U.S. States
por: Lapp, Zena, et al.
Publicado: (2023)

137 Developing an Approach to Evaluating the Quality of Antibiotic Prescribing in Hospitalized Patients with Community-Acquired Pneumonia (CAP) and Non-catheter Associated Urinary Tract Infection (UTI)
por: Fagan, Ryan, et al.
Publicado: (2014)

486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018
por: Grass, Julian E, et al.
Publicado: (2019)

1059. Staphylococcus aureus Bacteremia Treatment: Results From Pilot Surveillance in Four US States
por: Kabbani, Sarah, et al.
Publicado: (2018)

Reduction in the Prevalence of Healthcare-Associated Infections in U.S. Acute Care Hospitals, 2015 vs 2011
por: Magill, Shelley S, et al.
Publicado: (2017)

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
por: Bulens, Sandra N., et al.
Publicado: (2018)

1642 Identifying Targets for Prevention Through Clostridium difficile Population Surveillance
por: Dumyati, Ghinwa, et al.
Publicado: (2014)

Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
por: Band, Victor I., et al.
Publicado: (2021)

1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013
por: Kracalik, Ian, et al.
Publicado: (2018)

Factors associated with SARS-CoV-2 and community-onset invasive Staphylococcus aureus coinfection, 2020
por: Jackson, Kelly, et al.
Publicado: (2023)

1009. Measuring the quality of fluoroquinolone prescribing in hospitals: results from the Emerging Infections Program Hospital Prevalence Survey Antimicrobial Quality Assessment
por: Magill, Shelley S, et al.
Publicado: (2019)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016
por: Jackson, Kelly A., et al.
Publicado: (2018)

479. Trends in C. difficile Incidence, Mortality, and NAP1/027 Strain in the Population of Monroe County, New York
por: Hatwar, Trupti, et al.
Publicado: (2018)

Molecular Characterization of Carbapenem-Resistant Enterobacteriaceae in the USA, 2011–2015
por: Ansari, Uzma, et al.
Publicado: (2017)

2456. Methicillin-Resistant Staphylococcus aureus Bacteremia 30-Day Mortality During 2020 Compared to 2016-2019: Assessing the Impact of COVID-19
por: Biggs, Holly, et al.
Publicado: (2023)

357 Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in Georgia, Minnesota, and Oregon – 2012
por: Guh, Alice, et al.
Publicado: (2014)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

Assessment of the Appropriateness of Antimicrobial Use in US Hospitals
por: Magill, Shelley S., et al.
Publicado: (2021)

740. Healthcare-associated invasive Staphylococcus aureus among adults with prior COVID-19-associated hospitalization, 2020
por: Jackson, Kelly A, et al.
Publicado: (2023)

1836. Characteristics of Nursing Homes Associated With Self-reported Implementation of Centers for Disease Control and Prevention (CDC) Core Elements of Antibiotic Stewardship
por: Thompson, Nicola D, et al.
Publicado: (2018)

1859. Prevalence of Antimicrobial Use in US Hospital Patients, 2011 vs. 2015
por: Magill, Shelley S, et al.
Publicado: (2018)

111. Pediatric and Adolescent Sepsis Epidemiology and Clinical Characteristics, Emerging Infections Program, 2014–2015
por: Gokhale, Runa Hatti, et al.
Publicado: (2019)

2314. Hospitalizations and Antibiotic Use in the Year Prior to an Incident C. difficile Infection for Medicare Beneficiaries in Four States, 2016–2018
por: Hatfield, Kelly M, et al.
Publicado: (2022)

Socioeconomic Status Factors Associated with Increased Incidence of Community-Associated Clostridium difficile Infection
por: Skrobarcek, Kimberly, et al.
Publicado: (2017)

490. Comparison of Clostridium difficile Infection Outcomes by Diagnostic Testing Method
por: Guh, Alice, et al.
Publicado: (2018)

1640 Antibiotic Use Patterns in a Population with Long Term Care-Onset C. difficile Infection Developing after Recent Hospitalization
por: Felsen, Christina, et al.
Publicado: (2014)

1831. Point Prevalence and Epidemiology of Antimicrobial Use in US Nursing Homes, 2017
por: Thompson, Nicola D, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hv1u4jjdlbfpc507fd3ajc0iih